Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Potent 5-lipoxygenase inhibitors from Yakult Honsha

Aug. 9, 1996

Alliance signed for asthma disease management program

Aug. 9, 1996

Hoechst Marion Roussel receives marketing approval for Allegra

Aug. 9, 1996

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

Leukocyte elastase inhibitors reported by Sanofi Winthrop

July 26, 1996

FK-224 research update

July 26, 1996

Tryptase inhibitors described as immune-based inflammatory disorders treatment

July 26, 1996

Anti-IgE monoclonal antibody lawsuits settled

July 19, 1996

Kyoto Pharm. and Asahi Chem. to codevelop AKY-953

July 19, 1996

5-Lipoxygenase inhibitors reported by Pfizer

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...